The insulin resistance of the syndrome seems to be characterized by a defect in tissue availability or utilization of inositol mediator; therefore, the supplementation of that mediator would improve the intracellular effect of insulin [13, 14, 16, 17]. This evidence concerns the gene INS and Insulin resistance.